{"nct_id":"NCT00061633","title":"Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)","status":"COMPLETED","status_verified_date":"2019-01","start_date":"2003-06","start_date_type":null,"primary_completion_date":"2004-01","primary_completion_date_type":"ACTUAL","completion_date":"2004-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["CPIX"]}